文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

静脉系统超声对急性肾损伤亚型的诊断准确性

Diagnostic accuracy of venous system ultrasound for subtypes of acute kidney injury.
PubMed 文献 · Emerg Med J · 2024-04-22
一句话结论在急诊科,VExUS评分对心肾型AKI诊断准确性良好、对低血容量型一般,但不能识别肾性和全身血管扩张型,不应单独用于确定AKI病因。

这项多学科前瞻性队列研究在单中心学术急诊科开展一年,纳入150例成人AKI患者,用四步静脉系统超声方案(VExUS评分,先测下腔静脉,下腔静脉扩张时再查门静脉、肝静脉和肾静脉血流形态)评估病因亚型,亚型由肾内科和急诊科医师结合住院期间资料判定。低血容量最常见(66%),其次为心肾型(18%)、全身血管扩张型(8.7%)和肾性(7.3%)。诊断心肾型时VExUS分级>0的AUC为0.819(敏感度77.8%、特异度80.5%),下腔静脉最大径>20.4 mm的AUC为0.865(敏感度74.1%、特异度86.2%)。作者结论:VExUS对心肾型AKI诊断准确性良好、对低血容量型一般,但不能识别肾性和全身血管扩张型,不应单独用于急诊确定AKI病因。

要点

  • 150例急诊成人AKI中最终病因:低血容量66%、心肾型18%、全身血管扩张型8.7%、肾性7.3%。
  • 诊断心肾型AKI:VExUS分级>0的AUC 0.819(敏感度77.8%、特异度80.5%);下腔静脉最大径>20.4 mm的AUC 0.865(敏感度74.1%、特异度86.2%)。
  • 诊断低血容量型AKI:VExUS分级≤0的AUC 0.711(敏感度83.8%、特异度56.9%);下腔静脉最大径≤16.8 mm的AUC 0.736(敏感度73.7%、特异度68.6%)。
  • 肾性和全身血管扩张型AKI:所有参数均未达到足够的诊断性能。
  • 作者结论:VExUS评分不应单独用于确定急诊AKI的病因。

适用人群与场景

  • 单中心学术急诊科就诊的成人急性肾损伤(AKI)患者,研究期为一年。

诊断标准与关键阈值

  • VExUS评分为四步超声方案:先测量下腔静脉(IVC),当下腔静脉扩张时再检查门静脉、肝静脉和肾静脉的器官血流形态。
  • 心肾型AKI诊断阈值:VExUS分级>0;下腔静脉最大径>20.4 mm。
  • 低血容量型AKI诊断阈值:VExUS分级≤0;下腔静脉最大径≤16.8 mm。

研究设计与关键结果

  • 多学科前瞻性队列研究,单中心学术急诊科开展一年,纳入150例AKI成人患者;AKI亚型由肾内科和急诊科医师结合住院期间获得的资料判定。
  • 最终判定病因构成:低血容量66%、心肾型18%、全身血管扩张型8.7%、肾性7.3%。
  • 心肾型:VExUS分级>0的AUC 0.819,敏感度77.8%、特异度80.5%;下腔静脉最大径>20.4 mm的AUC 0.865,敏感度74.1%、特异度86.2%。
  • 低血容量型:VExUS分级≤0的AUC 0.711,敏感度83.8%、特异度56.9%;下腔静脉最大径≤16.8 mm的AUC 0.736,敏感度73.7%、特异度68.6%。
  • 肾性和全身血管扩张型:所有参数均未达到足够的诊断性能。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究(多学科、单中心学术急诊科,研究期一年,样本量150例)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:VExUS评分对心肾型AKI诊断准确性良好、对低血容量型准确性一般,但不能识别肾性和全身血管扩张型,因此不应单独用于确定急诊AKI的病因。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Management of acute kidney injury (AKI) in the ED can be difficult due to uncertainty regarding the aetiology. This study investigated the diagnostic value of venous system ultrasound for determining the aetiological subtypes of AKI in the ED.

METHODS: This multidisciplinary prospective cohort study was conducted in a single academic ED over the course of a year. Adult patients with AKI were evaluated using the venous excess ultrasound (VExUS) score, which is a four-step ultrasound protocol. The protocol begins with the inferior vena cava (IVC) measurement and examines organ flow patterns, including portal, hepatic and renal veins in the presence of dilated IVC. The AKI subtypes (hypovolaemia, cardiorenal, systemic vasodilatation and renal) were adjudicated by nephrologists and emergency physicians, considering data that became available during the hospitalisation. We determined the diagnostic test characteristics of VExUS for identifying each of the four AKI aetiological subtypes.

RESULTS: 150 patients with AKI were included in the study. Hypovolaemia was the most frequent finally adjudicated cause of AKI (66%), followed by cardiorenal (18%), systemic vasodilatation (8.7%) and renal (7.3%). In diagnosing the cardiorenal subtype, the area under the curve (AUC) for VExUS grade >0 was 0.819, with 77.8% sensitivity and 80.5% specificity, and the AUC for IVC maximum diameter >20.4 mm was 0.865, with 74.1% sensitivity and 86.2% specificity. For the hypovolaemia subtype, the AUC for VExUS grade ≤0 was 0.711, with 83.8% sensitivity and 56.9% specificity, and the AUC for IVC maximum diameter ≤16.8 mm was 0.736, with 73.7% sensitivity and 68.6% specificity. None of the parameters achieved adequate test characteristics for renal and systemic vasodilatation subtypes.

CONCLUSION: The VExUS score has good diagnostic accuracy for cardiorenal AKI and fair accuracy for hypovolaemic AKI but cannot identify renal and systemic vasodilatation subtypes. It should not therefore be used in isolation to determine the cause of AKI in the ED.

TRIAL REGISTRATION NUMBER: NCT04948710.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Aslaner MA, Helvacı Ö, Haycock K, et al. Diagnostic accuracy of venous system ultrasound for subtypes of acute kidney injury. Emerg Med J. 2024. PMID: 38355289. doi:10.1136/emermed-2023-213241

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。